User profiles for V Suryadevara

Vidyani Suryadevara

Department of Radiology, Stanford University
Verified email at stanford.edu
Cited by 458

[BOOK][B] Internet of things: Challenges and opportunities

SC Mukhopadhyay, NK Suryadevara - 2014 - Springer
The term Internet of things (IoT) is used to describe embedded devices (things) with Internet
connectivitsy, allowing them to interact with each other, services, and people on a global …

Spatial mapping of cellular senescence: emerging challenges and opportunities

…, S Victorelli, T Pengo, T Khaliullin, V Suryadevara… - Nature aging, 2023 - nature.com
Cellular senescence is a well-established driver of aging and age-related diseases. There
are many challenges to mapping senescent cells in tissues such as the absence of specific …

Artificial intelligence-based sensors for next generation IoT applications: A review

…, SKS Tyagi, NK Suryadevara… - IEEE Sensors …, 2021 - ieeexplore.ieee.org
Sensors play a vital role in our daily lives and are an essential component for Internet of
Things (IoT) based systems as they enable the IoT to collect data to take smart and intelligent …

[HTML][HTML] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

…, J Liu, JM Errico, X Xie, N Suryadevara… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …

[PDF][PDF] Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition

…, AS Dingens, RS Nargi, RE Sutton, N Suryadevara… - Cell host & …, 2021 - cell.com
Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are being developed
as therapeutics and are a major contributor to neutralizing antibody responses elicited …

[HTML][HTML] Potently neutralizing and protective human antibodies against SARS-CoV-2

…, A Trivette, RS Nargi, RE Sutton, N Suryadevara… - Nature, 2020 - nature.com
The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …

[HTML][HTML] Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

…, S Kyu, JC Howell, T Ozturk, S Lee, N Suryadevara… - Nature …, 2020 - nature.com
A wide spectrum of clinical manifestations has become a hallmark of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the …

Towards the implementation of IoT for environmental condition monitoring in homes

SDT Kelly, NK Suryadevara… - IEEE sensors …, 2013 - ieeexplore.ieee.org
In this paper, we have reported an effective implementation for Internet of Things used for
monitoring regular domestic conditions by means of low cost ubiquitous sensing system. The …

[HTML][HTML] Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

…, A Trivette, RS Nargi, RE Sutton, N Suryadevara… - Nature medicine, 2020 - nature.com
Antibodies are a principal determinant of immunity for most RNA viruses and have promise
to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 …

[PDF][PDF] Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan… - Cell, 2021 - cell.com
Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S)
protein receptor-binding domain and block virus interactions with the cellular receptor …